Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine.
about
A Human Trypanosome Suppresses CD8+ T Cell Priming by Dendritic Cells through the Induction of Immune Regulatory CD4+ Foxp3+ T CellsThe Combined Deficiency of Immunoproteasome Subunits Affects Both the Magnitude and Quality of Pathogen- and Genetic Vaccination-Induced CD8+ T Cell Responses to the Human Protozoan Parasite Trypanosoma cruziGenetic vaccination against experimental infection with myotropic parasite strains of Trypanosoma cruzi.CD8(+) T cell-mediated immunity during Trypanosoma cruzi infection: a path for vaccine development?Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infectionImmunomodulation by Trypanosoma cruzi: toward understanding the association of dendritic cells with infecting TcI and TcII populations.Vaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infectionA human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy.Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustion.Impairment of T cell function in parasitic infections.Patients with tuberculosis disease have Mycobacterium tuberculosis-specific CD8 T cells with a pro-apoptotic phenotype and impaired proliferative capacity, which is not restored following treatment.A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruziPromiscuous Recognition of a Trypanosoma cruzi CD8+ T Cell Epitope among HLA-A2, HLA-A24 and HLA-A1 Supertypes in Chagasic Patients.Utilizing the antigen capsid-incorporation strategy for the development of adenovirus serotype 5-vectored vaccine approaches.Relevance of long-lived CD8(+) T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination.Challenge of chronically infected mice with homologous trypanosoma cruzi parasites enhances the immune response but does not modify cardiopathy: implications for the design of a therapeutic vaccine.A Novel Vaccine Approach for Chagas Disease Using Rare Adenovirus Serotype 48 Vectors.Apoptotic CD8 T-lymphocytes disable macrophage-mediated immunity to Trypanosoma cruzi infection.Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents.Chagas Disease Diagnostic Applications: Present Knowledge and Future Steps.Adenovirus vector-induced CD8⁺ T effector memory cell differentiation and recirculation, but not proliferation, are important for protective immunity against experimental Trypanosoma cruzi InfectionChagas disease: still many unsolved issues.Prophylactic and therapeutic DNA vaccines against Chagas disease.Analysis of novel meningococcal vaccine formulations.Induction of death receptor CD95 and co-stimulatory molecules CD80 and CD86 by meningococcal capsular polysaccharide-loaded vaccine nanoparticlesImplication of Apoptosis for the Pathogenesis of Trypanosoma cruzi Infection.Antiparasitic Treatment Induces an Improved CD8+ T Cell Response in Chronic Chagasic Patients.LFA-1 Mediates Cytotoxicity and Tissue Migration of Specific CD8+ T Cells after Heterologous Prime-Boost Vaccination against Trypanosoma cruzi Infection.Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite.Proteomic and functional analysis identifies galectin-1 as a novel regulatory component of the cytotoxic granule machinery.Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection.Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation.Vaccination With Recombinant Filamentous fd Phages Against Parasite Infection Requires TLR9 Expression.Class-B CpG-ODN Formulated With a Nanostructure Induces Type I Interferons-Dependent and CD4 T Cell-Independent CD8 T-Cell Response Against Unconjugated Protein Antigen
P2860
Q27313504-9C512D6A-AD85-4CDC-BF25-D1E25C83447FQ27314524-B24561A6-8496-43E9-ABFC-174FD222E62AQ33902471-22C235FF-81F6-4731-9667-69162A9FB56BQ33914939-59C3140F-1903-4C54-8E78-C9AEC8964684Q34075166-64A5D04B-5236-478D-A05B-739361524977Q34413237-115ED99D-A40D-44C6-AE35-0559E1579E7DQ34700649-D61E9A2A-1B56-458C-B54A-5C749B77E96EQ35009081-DF83319B-0CB8-4DD5-BA09-6B901D906209Q35071882-302B5999-F8C0-4A93-9008-3EDBE6D89974Q35097790-4530C127-F1C4-458A-BB27-BBAC8B7B0103Q35150831-6F37225F-0042-483E-AA15-3F093976F34DQ35581314-EF38BF35-3585-4C78-8F90-19F6F056F263Q35955948-AEDD2A9C-9CD8-49B7-8D9E-15E61D83F3B0Q35973091-ED1CFF02-764D-473A-BC96-8AE60EFE993FQ36474557-84186080-E6FB-46F2-ACF2-EB7534033633Q36606779-B68C4AB2-684F-4A4F-90F5-DFA877B38221Q36735672-FC46C949-4243-4C95-97E4-D9BE94B54BE6Q37030324-80DC8B64-8ABE-4F35-A567-3EFA90377CADQ37546314-B4946EC1-3C2B-47B1-8EAC-225DA3987F7FQ37717875-ECA9C094-2A00-4FAC-A2FC-CA1AEB7908A7Q37719124-0A3B8FC3-1D5C-4C9D-9D82-ED3B29CA2540Q38238078-15B9AFB5-D628-43DE-8EBD-295070598BEAQ38426148-FC42A869-9E63-44A7-9C6A-FDEA59FE8F14Q38844408-8458AE2D-00EC-452B-A02C-47C7A023A721Q38979345-A3273002-30A9-462F-9CCC-4BFB20130C49Q39325453-9E7C6BDD-56C0-45C9-ADA6-CA0EC6C748D9Q40309242-F802F175-D502-4FFF-AACF-1C0E4434B280Q42682937-8FA3695D-53CF-40FA-8479-CBDD86BBC7F3Q42699604-2AB42746-C482-42FC-B886-0EAFE36A42B4Q47320158-E4B40EDF-CD24-4F86-A941-E70DB4A17B92Q48373108-1A9FA0F4-C50D-4807-A64E-CE0D41476666Q51316104-B37AF028-19CC-4165-99F0-C8CD3216C24EQ55094740-567EC5B9-1B66-4272-AE61-32ED82EB46F9Q58575827-99424E3B-F45F-484E-AE8E-9073F2B0E027
P2860
Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Pathogen-induced proapoptotic ...... eversal by adenoviral vaccine.
@ast
Pathogen-induced proapoptotic ...... eversal by adenoviral vaccine.
@en
Pathogen-induced proapoptotic phenotype and high CD95
@nl
type
label
Pathogen-induced proapoptotic ...... eversal by adenoviral vaccine.
@ast
Pathogen-induced proapoptotic ...... eversal by adenoviral vaccine.
@en
Pathogen-induced proapoptotic phenotype and high CD95
@nl
prefLabel
Pathogen-induced proapoptotic ...... eversal by adenoviral vaccine.
@ast
Pathogen-induced proapoptotic ...... eversal by adenoviral vaccine.
@en
Pathogen-induced proapoptotic phenotype and high CD95
@nl
P2093
P2860
P50
P1433
P1476
Pathogen-induced proapoptotic ...... reversal by adenoviral vaccine
@en
P2093
Adriano F Araújo
Alexandre V Machado
Gustavo P Amarante-Mendes
José Ronnie Vasconcelos
Mauricio M Rodrigues
P2860
P304
P356
10.1371/JOURNAL.PPAT.1002699
P50
P5008
P577
2012-05-17T00:00:00Z